- Home
- IOVA vs CNMD Comparison
IOVA vs CNMD Comparison
Compare IOVA & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- CNMD
- Stock Information
- Founded
- IOVA 2007
- CNMD 1970
- Country
- IOVA United States
- CNMD United States
- Employees
- IOVA N/A
- CNMD N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IOVA Health Care
- CNMD Health Care
- Exchange
- IOVA Nasdaq
- CNMD Nasdaq
- Market Cap
- IOVA 2.6B
- CNMD 2.2B
- IPO Year
- IOVA N/A
- CNMD 1987
- Fundamental
- Price
- IOVA $5.82
- CNMD $59.81
- Analyst Decision
- IOVA Strong Buy
- CNMD Buy
- Analyst Count
- IOVA 9
- CNMD 5
- Target Price
- IOVA $23.06
- CNMD $77.20
- AVG Volume (30 Days)
- IOVA 7.2M
- CNMD 523.8K
- Earning Date
- IOVA 02-26-2025
- CNMD 02-05-2025
- Dividend Yield
- IOVA N/A
- CNMD 1.31%
- EPS Growth
- IOVA N/A
- CNMD 108.33
- EPS
- IOVA N/A
- CNMD 4.25
- Revenue
- IOVA $90,858,000.00
- CNMD $1,307,015,000.00
- Revenue This Year
- IOVA $13,803.28
- CNMD $8.95
- Revenue Next Year
- IOVA $167.55
- CNMD $6.60
- P/E Ratio
- IOVA N/A
- CNMD $14.34
- Revenue Growth
- IOVA 12751.20
- CNMD 5.00
- 52 Week Low
- IOVA $5.05
- CNMD $60.74
- 52 Week High
- IOVA $18.33
- CNMD $86.96
- Technical
- Relative Strength Index (RSI)
- IOVA 49.38
- CNMD 34.28
- Support Level
- IOVA $5.44
- CNMD $60.74
- Resistance Level
- IOVA $5.80
- CNMD $65.50
- Average True Range (ATR)
- IOVA 0.31
- CNMD 2.55
- MACD
- IOVA 0.09
- CNMD -0.72
- Stochastic Oscillator
- IOVA 82.43
- CNMD 5.44
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.